Analyst firms · Goldman Sachs · ALEC

Goldman Sachs ALEC price target and rating history

Alector Inc. (ALEC) · Health Care

Goldman Sachs rates Alector Inc. (ALEC) Sell with a $4 price target, as of its latest action on Sep 25, 2023. It has published 3 rating actions on ALEC since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Sell
Price target
$4
Median target, all firms
Too few
Actions on ALEC
3

Goldman Sachs price target on ALEC

$33$19$420222023202420252026
Goldman Sachs price target on ALEC, each point a stated target, August 2021 to September 2023.

Every Goldman Sachs rating on ALEC

How other firms rate ALEC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$7Nov 13, 2026
Cantor FitzgeraldOverweightApr 15, 2026
BTIGBuy$6Mar 10, 2026

Questions about Goldman Sachs and ALEC

What is Goldman Sachs's price target for ALEC?
Goldman Sachs's latest stated price target for Alector Inc. (ALEC) is $4, from its action on Sep 25, 2023.
What is Goldman Sachs's rating on ALEC?
Goldman Sachs rates ALEC Sell, a bearish rating, as of Sep 25, 2023.
When did Goldman Sachs last change its view on ALEC?
On Sep 25, 2023, Goldman Sachs starts coverage at Sell, price target $4.

More ALEC rating histories

All Goldman Sachs ratingsALEC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.